其他臨床專科系

遺傳醫學科的依據指引

14 個學習主題共依據 19 份臨床指引與文獻。點主題名稱看它的學習重點。

染色體異常與核型分析2 份

  1. Clinical practice guidelines for the care of girls and women with Turner syndrome|European Journal of Endocrinology|2024
    Gravholt CH, Andersen NH, Christin-Maitre S, et al. · DOI · CC BY-NC 4.0
  2. Health Supervision for Children and Adolescents With Down Syndrome|Pediatrics|2022
    Bull MJ, Trotter T, Santoro SL, et al. · DOI

單基因遺傳病1 份

  1. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts|Frontiers in Genetics|2022
    Kingdom R, Wright CF · DOI · CC BY 4.0

先天性代謝異常1 份

  1. Suggested guidelines for the diagnosis and management of urea cycle disorders|E-IMD 歐洲共識小組|2012
    Häberle J, Boddaert N, Burlina A, et al. · DOI · CC BY 2.0

產前遺傳診斷與羊膜穿刺1 份

  1. Screening and diagnosis of fetal structural anomalies and chromosome conditions (C-Obs 35) Clinical Guideline v3.0|RANZCOG|2024

非侵入性產前篩檢1 份

  1. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the ACMG|ACMG|2023
    ACMG的全部指引 · Dungan JS, Klugman S, Darilek S, et al. · DOI

新生兒篩檢異常之追蹤2 份

  1. Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation|International Journal of Neonatal Screening|2025
    McGarry M, Raraigh K, Farrell P, et al. · DOI · CC BY 4.0
  2. Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)|JSPE + 日本 Mass Screening 學會|2021
    Nagasaki K, Minamitani K, Nakamura A, et al. · DOI · CC BY-NC-ND 4.0

遺傳性癌症症候群2 份

  1. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)|Gut|2019
    Monahan KJ, Bradshaw N, Dolwani S, et al. · DOI · CC BY-NC 4.0
  2. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history (CG164)|NICE|2013

帶因者篩檢與生育風險諮詢1 份

  1. Responsible implementation of expanded carrier screening(ESHG recommendations)|ESHG|2016
    Henneman L, Borry P, Chokoshvili D, et al. · DOI

次世代定序與變異致病性解讀1 份

  1. Points to consider in the reevaluation and reanalysis of genomic test results: an ACMG statement|ACMG|2019

藥物基因體學與用藥反應1 份

  1. CPIC Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update|CPIC|2025
    Maillard M, Schwab M, Whirl‐Carrillo M, et al. · DOI · CC BY-NC-ND 4.0

罕見疾病診斷與病人支持2 份

  1. Addressing psychosocial vulnerability in rare diseases: a call to action from a European expert consensus study|Orphanet Journal of Rare Diseases|2025
    Smits RM, Aerts A, Angelov T, et al. · DOI · CC BY 4.0
  2. International Undiagnosed Diseases Programs (UDPs): components and outcomes|Orphanet Journal of Rare Diseases|2023
    Curic E, Ewans L, Pysar R, et al. · DOI · CC BY 4.0

家族譜系繪製與風險評估2 份

  1. Practice resource‐focused revision: Standardized pedigree nomenclature update centered on sex and gender inclusivity: A practice resource of the National Society of Genetic Counselors|Journal of Genetic Counseling|2022
    Bennett RL, French KS, Resta RG, et al. · DOI
  2. Recommendations for Standardized Human Pedigree Nomenclature(NSGC Pedigree Standardization Task Force)|NSGC|1995

產前微陣列與基因拷貝數變異1 份

  1. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada|CCMG + SOGC|2018
    Armour CM, Dougan SD, Brock JA, et al. · DOI · CC BY-NC

使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入